Michael Losch is an experienced executive who has served as Chief Financial Officer (CFO) and/or Chief Administrative Officer (CAO) of public and private companies, as well as for profit and not for profit entities, on both a full time and consulting basis. For the past five years he has served as the Chief Financial Officer for Signum Biosciences, Inc., a biotech with offices in Princeton, NJ and Boulder, CO. Prior to that, he served as Chief Financial Officer, Secretary and Treasurer for entities as large as a Fortune 100 company and as small as startups seeking early stage funding. While at Tellium, Inc. the company grew from zero revenues to over $135 million in annual revenues, increased employees from 95 to over 550 and raised over $425 million including an IPO. At ACT Oncology, Inc. he was instrumental in establishing accounting and employee practices for the company as it doubled revenues annually and the business increased its valuation fivefold. He worked with MSD Capital to close a $20 million convertible credit agreement on behalf of BioEnergy of America, Inc. that related to the construction of a biofuels plant on the east coast. As the culmination of an early twenty year career with Verizon, Inc. (formerly Bell Atlantic), he rose to Chief Financial Officer for Bell Atlantic-New Jersey where his duties included acting as the chief accounting witness for the New Jersey Board of Public Utilities. Prior to that assignment he served as the Executive Director Investor Relations for the Bell Atlantic Corporation at a time it was the world’s third most widely held stock.
Mr. Losch continues to be active in the community as he has served on his local school board, the Chamber of Commerce, and the Board of Directors for the Raritan Bay Medical Center prior to its merger with Hackensack Meridian. He currently serves on the Board of the Big Brothers Big Sisters of Coastal and Norther New Jersey and the Friendly Sons of St. Patrick of the Jersey Shore